Transparency is the Victim
By The Hindu,
The Hindu
| 01. 27. 2013
Expansion and proliferation of assisted reproductive technologies (ART) has been facilitated by economic globalisation wherein reproductive tissues like sperm, ova, and uteri are traded like any other commodity to make profit, says a new study, adding that India has emerged as the surrogacy outsourcing capital of the world.
Titled ‘Reproductive Tourism in India: Actors, Agencies and Contemporary Transnational Networks’, the study was conducted by the Centre of Social Medicine and Community Health, JNU, Sama-Resource Group for Women and Health and King’s College London.
The study focuses on the scenario in New Delhi where a large number of private hospitals and government institutions offer ART. It was found that public sector institutions offer only altruistic surrogacy services which are medically indicated. Leading obstetricians and gynaecologists from a top government-run hospital admitted that they have performed in-vitro fertilisation (IVF) in some cases where they were not sure if it was altruistic surrogacy.
One doctor said that she once had a patient, a doctor by profession who bore a surrogate baby for her sister-in-law who was also a doctor, married to a doctor...
Related Articles
By Philip Bump, Washington Post | 07.07.2025
There are a lot of questions worth asking about the New York Times’s report on Thursday about New York City Democratic mayoral nominee Zohran Mamdani. The most obvious is how Mamdani’s racial self-identification in his 2009 application to Columbia University...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...